PRODUCTS & INNOVATION
As a senior scientist in Abbott’s diagnostics business, Mary Rodgers manages the Abbott Global Viral Surveillance Program and external collaborations for the infectious disease research division.
Abbott’s Global Surveillance Program was established two decades ago to detect and actively monitor emerging HIV and hepatitis strains around the world. By monitoring the diversity of current epidemics as well as the next public health threats, this program serves as the scientific foundation upon which Abbott’s diagnostic tests are built.
Mary received her Ph.D. in biological and biomedical sciences from Harvard University. She completed her postdoctoral training at the University of Southern California. Mary joined Abbott in 2014 and has since helped to complete the sequencing of 14 new divergent strains of HIV from the Congo basin using next generation technology. She also published a study describing more than 1,000 new viral sequences, including rare HIV Group N and O, HTLV-3, and recombinant hepatitis B virus strains from Cameroon.
Mary is a member of the American Association for the Advancement of Science and the American Society of Microbiology.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.